162 related articles for article (PubMed ID: 37387540)
1. DUSP10 is a novel immune-related biomarker connected with survival and cellular proliferation in lower-grade glioma.
Xiao F; Zhu H; Guo Y; Zhang Z; Sun G; Huang K; Guo H; Hu G
Aging (Albany NY); 2023 Jun; 15(12):5673-5697. PubMed ID: 37387540
[TBL] [Abstract][Full Text] [Related]
2. MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma.
Xiao F; Long Z; Guo Y; Zhu H; Zhang Z; Xiao Y; Hu G; Yang Q; Huang K; Guo H
Aging (Albany NY); 2023 Jun; 15(12):5713-5733. PubMed ID: 37390121
[TBL] [Abstract][Full Text] [Related]
3. CIA-II is associated with lower-grade glioma survival and cell proliferation.
Xiao F; Zhu H; Guo Y; Zhang Z; Sun G; Xiao Y; Hu G; Huang K; Guo H
CNS Neurosci Ther; 2024 Feb; 30(2):e14340. PubMed ID: 37452510
[TBL] [Abstract][Full Text] [Related]
4. PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma.
Xiao F; Jie X; Zhou X; Guo Y; Sun GF; Lin L; Hu GW; Huang K; Guo H
Biosci Rep; 2023 May; 43(5):. PubMed ID: 37083601
[TBL] [Abstract][Full Text] [Related]
5. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
[TBL] [Abstract][Full Text] [Related]
6. MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma.
Xiao F; Zeng J; Wang H; Zhu H; Guo Y; Zhang Z; Xiao Y; Hu G; Huang K; Yang Q; Guo H
Aging (Albany NY); 2023 May; 15(9):3690-3714. PubMed ID: 37166417
[TBL] [Abstract][Full Text] [Related]
7. The Dual-Specificity Phosphatase 10 (DUSP10): Its Role in Cancer, Inflammation, and Immunity.
Jiménez-Martínez M; Stamatakis K; Fresno M
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939861
[TBL] [Abstract][Full Text] [Related]
8. DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis.
Png CW; Weerasooriya M; Guo J; James SJ; Poh HM; Osato M; Flavell RA; Dong C; Yang H; Zhang Y
Oncogene; 2016 Jan; 35(2):206-17. PubMed ID: 25772234
[TBL] [Abstract][Full Text] [Related]
9. Identification of telomere-associated gene signatures to predict prognosis and drug sensitivity in glioma.
Zhou Q; Wang Y; Xin C; Wei X; Yao Y; Xia L
Comput Biol Med; 2024 Jan; 168():107750. PubMed ID: 38029531
[TBL] [Abstract][Full Text] [Related]
10. CNIH4: a novel biomarker connected with poor prognosis and cell proliferation in patients with lower-grade glioma.
Xiao F; Sun G; Zhu H; Guo Y; Xu F; Hu G; Huang K; Guo H
Am J Cancer Res; 2023; 13(5):2135-2154. PubMed ID: 37293170
[TBL] [Abstract][Full Text] [Related]
11. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
12. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.
Cheng X; Liu Z; Liang W; Zhu Q; Wang C; Wang H; Zhang J; Li P; Gao Y
Int J Biochem Cell Biol; 2023 May; 158():106409. PubMed ID: 36997057
[TBL] [Abstract][Full Text] [Related]
13. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
14. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract][Full Text] [Related]
15. DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma.
Zhou F; Zeng L; Chen X; Zhou F; Zhang Z; Yuan Y; Wang H; Yao H; Tian J; Liu X; Zhao J; Huang X; Pu J; Cho WC; Cao J; Jiang X
Front Oncol; 2022; 12():1050756. PubMed ID: 36713584
[TBL] [Abstract][Full Text] [Related]
16. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
17. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y; Feng Y; Luo F; Peng G; Li Y
Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
Xu S; Tang L; Liu Z; Luo C; Cheng Q
Front Immunol; 2021; 12():731048. PubMed ID: 34659218
[TBL] [Abstract][Full Text] [Related]
19. CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma.
Wang D; Sun H; Li X; Wang G; Yan G; Ren H; Hou B
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908101
[TBL] [Abstract][Full Text] [Related]
20. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
